Maxeeze

Paracetamol, caffeine and codeine phosphate hemihydrate, the active ingredients in Maxeeze, are analgesic and antipyretic agents presented as oral tablets for adult use. They provide relief of mild to moderate pain, headache and fever in patients requiring combined analgesic therapy.

GNH USA supplies Maxeeze as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Maxeeze combines paracetamol, caffeine and codeine to target pain and fever pathways.

- Mild to moderate pain: provides analgesic relief through synergistic action of the three components. - Headache: reduces headache intensity by acting on central pain mechanisms. - Fever: lowers elevated body temperature by inhibiting prostaglandin synthesis.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Drowsiness: increased sleepiness, especially after the first dose. - Constipation: reduced bowel movements. - Dizziness: transient light‑headedness. - Dry mouth: reduced salivation. - Loss of appetite: decreased hunger.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing, especially with high opioid exposure. - Dependence or addiction: risk of misuse with prolonged use. - Severe allergic reactions: rash, itching, swelling, or anaphylaxis. - Hepatotoxicity: liver injury if paracetamol dose exceeds safe limits. - Opioid‑induced constipation leading to bowel obstruction. - Stevens‑Johnson syndrome or toxic epidermal necrolysis: rare severe skin reactions.

Before using Maxeeze, consider the following precautions.

- Pregnancy: consult a healthcare professional; safety data are limited. - Respiratory disorders: use with caution in patients with asthma or COPD due to opioid‑related breathing effects. - Alcohol consumption: avoid concurrent intake as it may increase sedation and liver risk. - Driving or operating machinery: may cause drowsiness; refrain until the effect is known. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Maxeeze may interact with several medicines; review the following categories.

Major Interactions (Avoid): - Other opioids: additive respiratory depression and sedation. - MAO inhibitors: risk of severe sedation and hypotension. - Central nervous system depressants (e.g., benzodiazepines): heightened drowsiness. - Alcohol: enhanced CNS depression and liver strain. - Anticholinergic agents: increased risk of constipation.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): possible serotonin syndrome. - Diuretics: may exacerbate urinary retention. - Antihistamines: additive sedative effects. - CYP2D6 inhibitors: may alter codeine metabolism and efficacy. - Anticoagulants: potential for altered bleeding risk due to paracetamol.